Technology ID
TT-0121
Description
MeticTouch® is an innovative non-invasive ocular drug delivery technology that offers a patient-friendly approach to administering medications to the eye. By eliminating the need for injections, MeticTouch® improves comfort, convenience, and potentially enhances treatment outcome.
Content
Innovative Delivery: MeticTouch® is the world’s first non-invasive ocular drug delivery technology that has shown a solid safety profile and effectiveness across various ocular conditions
Pharma Compatibility: Designed to seamlessly integrate with both existing and new drug products without requiring reformulation, MeticTouch® is highly adaptable to a broad range of therapeutics
Customizable Solutions: MeticTouch® can be tailored to meet the strategic needs of biopharmaceutical companies, enhancing the value proposition of both new and established drugs
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL
IP Status
Patent Pending
Images
